Article Versions Notes

Critelli RM, Casari F, Borghi A, Serino G, Caporali C, Magistri P, Pecchi A, Shahini E, Milosa F, Di Marco L, et al. The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment. Cancers. 2024; 16(20):3549. https://doi.org/10.3390/cancers16203549

Critelli, Rosina Maria, Federico Casari, Alberto Borghi, Grazia Serino, Cristian Caporali, Paolo Magistri, Annarita Pecchi, Endrit Shahini, Fabiola Milosa, Lorenza Di Marco, and et al. 2024. "The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment" Cancers 16, no. 20: 3549. https://doi.org/10.3390/cancers16203549

Critelli, R. M., Casari, F., Borghi, A., Serino, G., Caporali, C., Magistri, P., Pecchi, A., Shahini, E., Milosa, F., Di Marco, L., Pivetti, A., Lasagni, S., Schepis, F., De Maria, N., Dituri, F., Martínez-Chantar, M. L., Di Benedetto, F., Giannelli, G., & Villa, E. (2024). The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment. Cancers, 16(20), 3549. https://doi.org/10.3390/cancers16203549